Stock News

What Are the Implications of Gilead’s Increased Focus on Oncology? 5-Star Analyst Weights In
Gilead Sciences (GILD) Leads Search for COVID-19 Vaccine
Is Remdesivir a Disappointment?
Better Buy: Bristol Myers Squibb vs. Gilead Sciences
Galapagos shares rise on Phase 3 studies of arthritis drug it's making with Gilead
Filgotinib Demonstrates Durable Efficacy and Consistent Safety Profile at 52 Weeks in FINCH 1 and 3 Studies in Rheumatoid Arthritis
Wait for More Clarity Before Buying Gilead Stock, Says Analyst
Gilead's remdesivir could see $7 billion in annual sales on stockpiling boost: analyst
Gilead Analyst: Coronavirus Drug, Arcus Collaboration Make Biopharma A Buy
Gilead Upgraded With Covid Sales Seen Reaching $7.7 Billion
Gilead's stock upgraded on high hopes for remdesivir revenue

As seen on...